Figure 4.

Kaplan-Meier Curves Demonstrating the Prognostic Effect of Multiorgan Baseline ECVs and Treatment Response, Followed by a Univariable Cox Proportional Hazards Regression Analysis

(A) Kaplan-Meier curve comparing survival in patients with a normal myocardial ECV, mildly increased myocardial ECV, moderately increased myocardial ECV, and severely increased myocardial ECV at diagnosis. (B) Kaplan-Meier curve comparing survival in patients with a normal liver ECV subclinical increase in liver ECV and clinically significant increase in liver ECV at diagnosis. (C) Kaplan-Meier curve comparing survival in patients with a normal spleen ECV subclinical increase in spleen ECV and clinically significant increase in spleen ECV at diagnosis. Abbreviation as in Figure 1.